MARINUS
Live / Registered — Registered (as of 05 Dec 2023)
What this means for you
Registered since 05 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97139236
- Registration number
- 7237360
- Mark type
- Design + words
- Filed
- 23 Nov 2021
- Published for opposition
- 18 Oct 2022
- Registered
- 05 Dec 2023
- Attorney of record
- Keith Barritt
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, epileptic encephalopathies, encephalopathies, seizures, genetic seizure disorders, movement disorders, neurologic conditions, neurodegenerative disease, cerebrovascular disease, traumatic brain injury, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, psychiatric conditions, and depression
Owner
- Marinus Pharmaceuticals, Inc., Radnor, PA, US
- Marinus Pharmaceuticals, Inc., Radnor, PA, US
- Marinus Pharmaceuticals, Inc., Radnor, PA, US
Prosecution history
- 05 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 03 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Sept 2023 — USE AMENDMENT FILED
- 10 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Sept 2023 — TEAS STATEMENT OF USE RECEIVED
- 25 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jan 2023 — SOU EXTENSION 1 GRANTED
- 23 Jan 2023 — SOU EXTENSION 1 FILED
- 23 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 13 Dec 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Oct 2022 — PUBLISHED FOR OPPOSITION